How do we prevent the burden of extremely harmful and clinically nonbeneficial drug–drug interactions among chronic kidney disease patients?

How do we prevent the burden of extremely harmful and clinically nonbeneficial drug–drug interactions among chronic kidney disease patients?

The chronic intake of different medications by chronic kidney disease (CKD) patients predisposes them to extremely harmful and clinically nonbeneficial drug–drug interactions (DDIs) which can ultimately lead to increase in morbidity, mortality, healthcare cost, and frequency and length of hospitaliz...

Full description

Bibliographic Details
Main Authors: Olumuyiwa John Fasipe, Sunday Olufemi Olayemi, Akinwumi Akinyinka Akinyede, Patrick Olanrewaju Osho, Oluwatosin Beatrice Ibiyemi-Fasipe, Evelyn Salewa Osho
Format: Article
Language:English
Published: SAGE Publishing 2018-09-01
Series:Toxicology Research and Application
Online Access:https://doi.org/10.1177/2397847318794861

Similar Items

Similar Items